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Coronary artery diseasePericardial adipose tissue has been increasingly attracting
physicians’ attention in association with metabolic syndrome and
cardiovascular disease. This fat tissue covers the surface of the
heart and surrounds adventitia of coronary arteries, and the close
relationship between the volume of the pericardial fat and
coronary artery disease motivates physicians and researchers for
further investigation. The recent advance in medical imaging
technology enables us to quantify the pericardial adipose tissue
using multi-detector computed tomography (MDCT), magnetic
resonance imaging, and echocardiography; however, the method
to measure the fat volume has not been standardized in any
imaging modalities.
In this issue of the journal, Okura et al.measured pericardial fat
volume by MDCT and demonstrated that accumulation of the
normalized pericardial fat volume was related to increased
severity of coronary artery disease in patients with preserved
ejection fraction [1]. There is some confusion in the literature
regarding the deﬁnition of pericardial fat. The pericardial fat is
somehow a loose terminology. The true visceral adipose tissue
surrounding myocardium is epicardial adipose tissue (EAT) or
subepicardial fat (Fig. 1). This fat is located below the parietal
pericardium. On the other hand, the fat deposited outside the
parietal pericardium is para-cardiac fat or paracardial fat [2]. It is
also referred to as thoracic fat or intrathoracic fat [3], and some
investigators call this fat ‘‘pericardial fat’’ because this fat adjusted
to outer surface of the pericardium (pericardi-al fat). However,
some use the terms pericardial fat and EAT interchangeably, and
the others use this term as the fat deposit either inside the visceral
pericardium or outside the parietal pericardium, i.e. the EAT plus
paracardial fat, that is, all the fat close to the heart (peri-cardial
fat). The EAT andmyocardium share the same coronary blood ﬂow
and inﬂuence each other [4], while the paracardial fat originates
from primitive thoracic mesenchyme, and it is supplied by
noncoronary sources. Thus, it is important to distinguish these
two different pericardial visceral fat depots in the view of
pathophysiology and in evaluating relationships with coronaryDOI of original article: http://dx.doi.org/10.1016/j.jjcc.2014.03.015.
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Framingham Heart Study and the Multi-Ethnic Study of Athero-
sclerosis do not seem to discriminate between these two [5],
dealing with ‘‘pericardial fat’’ as any adipose tissue located near
pericardial sac. Okura et al. were also not able to distinguish EAT
fromparacardiac fat by a 64 detector rowCT systemandmeasured
‘‘pericardial fat’’ as a complex of epicardial fat, pericardium, and
paracardial fat. Consequently they omitted a discussion about
speciﬁc EAT. The pericardial fat volume measured by 64-slice
MDCT could be one of the important cardiovascular risk factors,
because of the biochemical and biomolecular properties and
anatomically close connection to coronary arteries, the EAT
conceptually could have more direct relationship between
coronary artery diseases. Hence, further studies will be necessary
to clarify this issue.
Echocardiography is the modality that can easily distinguish
the EAT from paracardial fat. However only thickness can be
measured by normal scanning, and the volume of the fat cannot be
obtained even using 3-dimensional echocardiography [6]. The
linear measurement of the fat thickness at a speciﬁc location may
not reﬂect the total EAT volume. Thus, in terms of quantiﬁcation,
MDCT by which one can measure 3-dimensional fat volume may
be more sensitive and speciﬁc than echocardiography. The
interobserver reliability and intraobserver reproducibility of
measuring EAT thickness are higher by MDCT than by echocardi-
ography.While Okura et al. could not measure the EAT volume, the
EAT can be distinguished from thoracic fat using the latest MDCT
machine [3]. The EAT volume, rather than its thickness, may be the
most consistent measure of risk [7]. However, echocardiographic
EAT thickness is still useful because it is inexpensive, reproducible,
repeatable, and still a direct measure of visceral fat without X-ray
exposure.
It has been reported that higher inﬂammatory markers were
observed in the EAT than in the subcutaneous adipose tissue in
patients with coronary artery disease [8]. Several researchers
reported that dense macrophage, T-lymphocyte, and mast cell
inﬁltration were observed in the EAT, but not in the subcutaneous
fat in patients with coronary artery disease [9,10]. Although the
role of the pericardial fat is not fully recognized, the volume has
been associated with coronary artery disease. Recent meta-
analysis in nine studies showed a statistically signiﬁcant increase
in the EAT thickness at the right ventricular free wall in the
coronary artery disease group compared to the non-coronary
artery disease group [11]. Furthermore, in the population-based
Heinz Nixdorf Recall cohort study, a signiﬁcant association of EAT
volume with cardiovascular risk factors was found and the EATss under CC BY-NC-ND license.
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Fig. 1. Identiﬁcation of epicardial adipose tissue and paracardial fat by echocardiography (left) and contrast enhanced 320-slicemulti-detector computed tomography (right).
The asterisks (*) indicate left descending coronary artery. ‘‘Pericardial fat’’ includes both epicardial fat (located within or deep into the pericardium) and paracardial fat
(located superﬁcial to the pericardium). Sometimes, pericardial fat is referred to as paracardial fat.
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Fig. 2. Echocardiograms from a 48-year-old man suffering from acute myocardial infarction. One day after the onset echocardiographic thickness of epicardial adipose tissue
(EAT) was 12 mm (A). The thickness reduced to 8 mm after 6 months of cardiac rehabilitation (B). PCF, paracardial fat.
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independent of traditional cardiovascular risk factors [3]. Since
gender and ethnic-speciﬁc differences in the EAT volume have
been reported [12], one should take care of these differences in
evaluating cardiovascular risk by EAT parameters.
Whether the volume of EAT can be reduced with interventions
and whether this will reduce risk of events remains to be
demonstrated. We experienced a case of a 48-year-old man
suffering from acute myocardial infarction whose echocardio-
graphic EAT thickness reduced in 6 months with cardiac
rehabilitation (Fig. 2). Regression of EAT has been observed in
subjects who underwent weight loss [13], exercise [14], atorvas-
tatin administration [15], ezetimibe therapy [16], and so on.
The physiological functions of EAT include protection of
coronary artery from tension or torsion and heat, an energy
source of myocardium, and neurological role for the cardiac
nervous system. It is likely the EAT plays an important role in
modulating cardiac function; however, excess EAT becomes
harmful as discussed above. Whether quantiﬁcation of the EATmay really have the diagnostic properties to serve as an indicator of
cardiovascular risk should be analyzed in large, randomized, and
multiethnic populations.
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